CADLCandel Therapeutics, Inc.
$8.01+52% 1Y
$8.01
$4.4252 weeks$13.76
Latest close: below its 200-day averageOct 23, 2026what changed →
Is the price fair?
What CADL's price assumes
- Price / book
- 6.05
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 6.05
- Market capitalisation76.5 million shares, counted Aug 6, 2026
- $613M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.